Company news

GSK plc news in 2025

GSK plc's news releases, calls and decks from 2025, newest first.

View company

Transaction in Own Shares

December 22, 2025

GSK to lower drug prices and expand access in US

December 22, 2025

Avantor® Appoints Simon Dingemans to its Board of Directors

December 18, 2025

Exdensur (depemokimab ulla) approved by US FDA

December 17, 2025

Exdensur (depemokimab) UK MHRA approval

December 16, 2025

Nucala receives positive CHMP opinion for COPD

December 12, 2025

Depemokimab receives positive CHMP opinion

December 12, 2025

Positive CHMP opinion on Arexvy for all adults 18+

December 12, 2025

Blujepa approved in US for gonorrhoea indication

December 11, 2025

Block Listing Application

December 11, 2025

GSK'227 US FDA Orphan Drug Designation in SCLC

December 10, 2025

Initiation of litigation against AnaptysBio Inc

November 21, 2025

Transfer of Treasury Shares

November 19, 2025

Block listing Interim Review

November 12, 2025

GSK publishes provisional dividend dates

November 10, 2025

3rd Quarter Results

October 29, 2025

GSK ADC gets orphan drug designation in the EU

October 28, 2025

Blenrep approved by US FDA in multiple myeloma

October 24, 2025

Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma

October 23, 2025

Positive data for low carbon version Ventolin MDI

October 22, 2025

Latozinemab data read out

October 22, 2025

Positive CHMP Opinion for GSK on Shingrix PFS

October 21, 2025

GSK share positive Ph3 data on tebipenem HBr

October 21, 2025

SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study

October 15, 2025

GSK receives expanded Shingrix approval in China

October 14, 2025

New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level

October 1, 2025

GSK - third tranche of share buyback programme

September 30, 2025

GSK appoints CEO designate

September 29, 2025

GSK US Investment Announcement

September 17, 2025

BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer

August 20, 2025

FDA to review gonorrhea indication for gepotidacin

August 11, 2025

CureVac/BioNTech mRNA patent litigation settlement

August 8, 2025

Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma

August 7, 2025

2nd Quarter Results

July 30, 2025

GSK enters Hengrui Pharma collaboration agreements

July 28, 2025

Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

July 27, 2025

Blenrep approved in the EU for multiple myeloma

July 24, 2025

US FDA review extended for Blenrep

July 23, 2025

Blenrep US ODAC outcome

July 18, 2025

US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation

July 17, 2025

GSK’s Shingrix Fully Liquid FDA approval

July 17, 2025

GSK submits Arexvy for adults 18-49 AIR to FDA

July 14, 2025

GSK begins shipping influenza vaccine doses for the 2025-26 flu season

July 10, 2025

Hansa Biopharma appoints Dr Richard Philipson as Chief Medical Officer

July 8, 2025

GSK completes acquisition of efimosfermin for SLD

July 7, 2025

Director Declaration

June 24, 2025

FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis

June 24, 2025

Replacement - Director/PDMR Shareholding

June 23, 2025

Replacement RNS: Linerixibat file accepted by EMA

June 23, 2025

GSK Submits Arexvy for adults 18+ with EMA

June 23, 2025

Older news releases →

Calls in 2025

Decks in 2025